Representative Daniel Pae

Hi, I’m Daniel Pae and I represent the people of Oklahoma’s 62nd District.


representative

Leadership

Assistant Majority Whip

60th Legislature

News & Announcements


Jun 30, 2026
Recent Posts

Pae, Pederson Applaud Taiwan Regional Trade Office Opening

Rep. Daniel Pae, R-Lawton, and Sen. Roland Pederson, R-Burlington, celebrated the official opening of Oklahoma's Taiwan Regional Trade Office, a move the lawmakers said marks a major milestone in the state's efforts to strengthen international trade. The office, housed within the Oklahoma Department of Commerce, officially opened during a ribbon-cutting ceremony at the Oklahoma State Capitol on Tuesday. Pae and Pederson, who authored SB209 , said the office will build on an already strong relationship between Oklahoma and Taiwan. "Taiwan has been a valued economic partner and friend for decades, and this office will help open new doors for investment, innovation and job creation," Pae said. "Oklahoma's economy continues to grow because we are willing to think globally and pursue partnerships that benefit our communities. I look forward to seeing the economic opportunities that grow from this office in the coming years." "Oklahoma's longstanding sister-state relationship with Taiwan has been a valuable partnership for many years, and today's opening of the Taiwan Regional Trade Office builds on that strong foundation," Pederson said. "By expanding trade and encouraging investment, this office will help create new opportunities for Oklahoma businesses and communities. I was proud to author the legislation establishing this office, and I'm grateful to Rep. Pae for his partnership in helping turn that vision into a reality for the benefit of Oklahoma and Southeast Asia." SB209, approved by the Legislature in 2025, became law without the governor's signature and took effect in August.



May 8, 2026

House recognizes May 2026 as Asian American Pacific Islander Heritage Month

OKLAHOMA CITY – House members Leader Cyndi Munson, D-Oklahoma City, Rep. Andy Fugate, D-Del City, and Rep. Daniel Pae, R-Lawton, filed HR 1059 to recognize May 2026 as Asian American Pacific Islander Month. AAPI Month is to recognize the contributions of the AAPI community and culture in Oklahoma and the United States. “I am proud to co-author this resolution, and doing so is uniquely special as the first Asian American woman elected to the Oklahoma Legislature. This resolution acknowledges the Oklahoma House of Representatives’ celebration of AAPI-owned businesses, history, and culture. My younger self needed to see someone like me in leadership. It is never lost on me how meaningful it is to show up to represent myself and all Asian American women and girls in Oklahoma. The Asian American community has had and continues to have an incredible impact on Oklahoma and the United States, and I am grateful to join my colleagues in this celebration of our heritage and culture.” – House Democratic Leader Cyndi Munson, D-Oklahoma City. “I proudly co-author this resolution recognizing the contributions of Oklahoma’s vibrant Asian American Pacific Islander population. Being one of the three AAPI voices serving in the Oklahoma Legislature, I deeply understand the need and importance of having diverse voices and perspectives included in the business we conduct here at the Oklahoma State Capitol. I encourage those who are able to shop at AAPI-owned businesses and attend events featured this month to further the appreciation and celebration of AAPI people.” – House Democratic Floor Leader Andy Fugate, D-Del City. “Asian American and Pacific Islander Heritage Month recognizes and celebrates the countless contributions AAPI communities have made to our state and nation. It is a time to celebrate the generations of Asian Americans and Pacific Islanders whose contributions have helped strengthen our communities and our country. This is also an opportunity to reflect on the importance of preserving our cultural heritage while continuing to build a future rooted in opportunity, freedom and respect for every Oklahoman. I'm proud to join in recognizing the impact AAPI families have made across our state and nation.” – Rep. Daniel Pae, R-Lawton. -END-



Apr 23, 2026
Recent Posts

Pae Applauds Federal Action to Fast-Track Psychedelic Research

Rep. Daniel Pae, R-Lawton, praised recent action by President Donald Trump to accelerate federal approval pathways for psychedelic-assisted therapies targeting mental health and addiction. Pae has authored several measures in recent years to study the use of certain psychedelic drugs for such treatments. The executive order directs the U.S. Food and Drug Administration to fast-track review of psychedelic therapies and expand research access for patients suffering from serious conditions such as depression and substance use disorders. It expands access to experimental treatments, including through pathways like the federal Right to Try Act . "President Trump's executive order marks a major step forward in addressing our nation’s mental health and addiction crises," Pae said. "Emerging research shows these treatments could offer real hope for individuals who have exhausted traditional options. I commend President Trump for responsibly accelerating research so we can better understand these tools and, if proven safe, make them available to those who desperately need help. I look forward to continuing this work in Oklahoma and supporting further study at both the state and federal level." Last year, Pae introduced House Bill 4293 to expand research opportunities and further evaluate the safety and efficacy of psychedelic treatments for Oklahomans struggling with mental illness and addiction. In 2024, he passed House Bill 2107 , which established a pilot program to study the use of psilocybin-assisted therapy for certain mental health conditions. The measure was approved in the House but was not heard in the Senate. Growing evidence suggest that psychedelic compounds may have significant therapeutic potential for treatment-resistant depression and substance use disorders when used in controlled, clinical settings. A 2025 study found that a single dose of lysergide, combined with psychotherapy, could ease anxiety for up to a year.